arrow_left You’re on the news side, go back to data on Abbvie.De

Latest news about Abbvie.De

4 days ago

There has been 14 news about Abbvie.De in the past from 5 different sources and amongst 2 sections

dataset_white Full dataset

Evolution

Here is the latest:

Financial Times
AbbVie shares tumble after schizophrenia drug disappoints
Read link
Nov 13, 2024
CNBC News
Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more
Read link
Nov 12, 2024
Quartz
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
Read link
Nov 01, 2024
Financial Times
Copycats take bite out of AbbVie's best-selling Humira drug
Read link
Apr 25, 2024
The Wall Street Journal
$19 Billion in a Week: AbbVie Makes Two Big Bets
Read link
Dec 08, 2023
The Wall Street Journal
$19 Billion in a Week: AbbVie Makes Two Big Bets
Read link
Dec 08, 2023
CNBC News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Read link
Dec 07, 2023
The Wall Street Journal
AbbVie to Buy Cerevel Therapeutics for $8.7 Billion
Read link
Dec 06, 2023
The Wall Street Journal
AbbVie has agreed to buy biotech ImmunoGen for $10.1 billion in a bet on a promising novel drug technology for attacking cancer.
Read link
Dec 01, 2023
CNBC News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Read link
Nov 30, 2023

Distribution by section

The coverage span across 2 distinct sections:

Distribution by publisher

There has been 5 publishers reporting on this, here are the top ones:

  • The Wall Street Journal (36%)
  • Quartz (21%)
  • CNBC News (21%)
  • Financial Times (14%)
  • Chicago Tribune (7%)

Details

This content can be used under the CC BY 4.0 license